Sophiris Bio Cuts Initial Public Offering Price
By Catherine Shaffer
Friday, August 16, 2013
Following a 1-for-52 reverse stock split of common shares traded on the Toronto Stock Exchange, Sophiris Bio Inc., of La Jolla, Calif., slashed its planned public offering price from $13 per share to $5 per share, while increasing the number of shares offered to maintain a target of $65 million in gross proceeds.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.